MDT vs PRME · P/E 21, rev $36.36B vs rev $4.6M
Medtronic PLC (MDT) versus Prime Medicine, Inc. Common Stock (PRME) — a side-by-side from cached financials, not a winner call.
Medtronic PLC (MDT) is a medical devices company listed on US.
Prime Medicine, Inc. Common Stock (PRME) is a biotechnology company listed on NASDAQ.
Latest reported MDT revenue for 2026-04-24 was $36.36B. Net income was $4.80B. Revenue was up 8.4% from 2025-04-25 to 2026-04-24. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
Latest reported PRME revenue for 2025-12-31 was $4.6M. Net income was -$201.1M. Revenue was up 55.3% from 2024-12-31 to 2025-12-31. PRME currently screens at market cap $570.8M.
MDT currently screens at market cap $100.08B and trailing P/E 20.9. PRME currently screens at market cap $570.8M.
Not investment advice. Open the MDT and PRME stock pages for the full models.
Not investment advice.